RTI Surgical Announces First Implantation of map3™ Cellular Allogeneic Bone Graft in a Foot and Ankle Procedure

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a global surgical implant company, is pleased to announce the first implantation of the company’s map3™ Cellular Allogeneic Bone Graft implant in a foot and ankle procedure.

Help employers find you! Check out all the jobs and post your resume.